Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine/Atorvastatin Fixed Combination in Concurrent Hypertension and Hyper-LDL-Cholesterolemia
NCT00530946Phase 3Completed
- Sponsor
- Viatris
- Start
- Sep 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of amlodipine and atorvastatin in hypertension (HTN) and hypercholesterolemia (4 arms), sponsored by Viatris. Primary endpoints: Change in Systolic Blood Pressure at 8 weeks and Percent Change in Low Density Lipoprotein-Cholesterol at 8 weeks. Started Sep 2007; status: completed.
02
Drugs
amlodipineatorvastatin
03
Conditions
hypertension (HTN)hypercholesterolemia
Beyond the preview
Go deeper on NCT00530946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00530946.